Wirusowe zapalenie wątroby typu a
Diagnostyka i diagnoza

Diagnostyka wirusowego zapalenia wątroby typu A (WZW A) opiera się przede wszystkim na badaniach serologicznych wykrywających specyficzne przeciwciała przeciwko wirusowi HAV. Kluczowym markerem ostrego zakażenia jest obecność przeciwciał klasy IgM (anty-HAV IgM), które pojawiają się 5-10 dni przed objawami klinicznymi (15-45 dni po ekspozycji) i utrzymują się zwykle 3-6 miesięcy, choć w 25% przypadków nawet do 12 miesięcy. Wysoka czułość i swoistość testów anty-HAV IgM (99-100%) umożliwia potwierdzenie ostrego zakażenia u pacjentów z objawami klinicznymi i podwyższonymi aminotransferazami (ALT, AST), które mogą osiągać wartości do 1000 j/l. Przeciwciała IgG pojawiają się we wczesnej rekonwalescencji i utrzymują się latami, świadcząc o przebytej infekcji lub odporności poszczepiennej. Diagnostyka uzupełniana jest badaniami biochemicznymi (bilirubina, fosfataza alkaliczna, albuminy, czas protrombinowy) oraz molekularnymi metodami RT-PCR wykrywającymi RNA HAV, szczególnie przydatnymi we wczesnej fazie zakażenia i badaniach epidemiologicznych.

Diagnostyka wirusowego zapalenia wątroby typu A

Wirusowe zapalenie wątroby typu A (WZW A) jest chorobą zakaźną wywoływaną przez wirus HAV (hepatitis A virus), który jest przenoszony drogą pokarmową. Diagnoza WZW typu A wymaga przeprowadzenia odpowiednich badań laboratoryjnych, ponieważ objawy kliniczne i cechy epidemiologiczne nie pozwalają na jednoznaczne odróżnienie zakażenia HAV od innych typów zapalenia wątroby12. Wczesne rozpoznanie ma kluczowe znaczenie dla zapobiegania dalszej transmisji wirusa poprzez szybkie wdrożenie profilaktyki poekspozycyjnej u osób z kontaktu3.

Badania laboratoryjne w diagnostyce WZW A

Podstawą diagnostyki WZW A są badania serologiczne, które opierają się na wykrywaniu w surowicy specyficznych przeciwciał przeciwko wirusowi zapalenia wątroby typu A45. Główne markery laboratoryjne wskazujące na ostre zakażenie HAV to:

Markery serologiczne w diagnostyce WZW A

W diagnostyce WZW A najczęściej wykorzystuje się następujące testy serologiczne78:

Przeciwciała anty-HAV klasy IgM

Przeciwciała klasy IgM (immunoglobulina M) przeciwko HAV są głównym markerem ostrego zakażenia4. Stają się wykrywalne w ciągu 5-10 dni przed wystąpieniem objawów klinicznych, czyli około 15-45 dni po ekspozycji910. Charakteryzują się wysoką czułością i swoistością diagnostyczną, osiągającą 99-100%11. Zazwyczaj utrzymują się w surowicy przez okres 3-6 miesięcy od momentu zakażenia, choć w około 25% przypadków mogą być wykrywalne nawet do 12 miesięcy512.

Wykrycie przeciwciał anty-HAV IgM w surowicy pacjenta z objawami klinicznymi i biochemicznymi cechami ostrego zapalenia wątroby potwierdza rozpoznanie ostrego WZW A13. Należy pamiętać, że testy na obecność anty-HAV IgM powinny być wykonywane tylko u pacjentów z objawami sugerującymi zakażenie HAV142.

Przeciwciała anty-HAV klasy IgG

Przeciwciała klasy IgG (immunoglobulina G) przeciwko HAV pojawiają się we wczesnej fazie rekonwalescencji, zaraz po przeciwciałach IgM157. Utrzymują się przez wiele lat, a nawet przez całe życie, zapewniając długotrwałą odporność na ponowne zakażenie HAV1516.

Wykrycie przeciwciał anty-HAV IgG przy jednoczesnym braku przeciwciał anty-HAV IgM świadczy o przebytym w przeszłości zakażeniu HAV lub o odporności poszczepiennej, a nie o ostrym zakażeniu1718.

Całkowite przeciwciała anty-HAV

Test na całkowite przeciwciała anty-HAV wykrywa zarówno przeciwciała klasy IgM, jak i IgG12. Dodatni wynik testu na całkowite przeciwciała anty-HAV może świadczyć o19:

  • Aktualnym zakażeniu HAV
  • Przebytym w przeszłości zakażeniu HAV
  • Odporności poszczepiennej

Testy na całkowite przeciwciała anty-HAV lub wyłącznie na anty-HAV IgG nie są przydatne w diagnostyce ostrego zakażenia HAV141. Badanie to może być natomiast pomocne w ocenie statusu immunologicznego pacjenta18.

Interpretacja wyników testów serologicznych

Prawidłowa interpretacja wyników testów serologicznych w kierunku WZW A ma kluczowe znaczenie dla postawienia właściwej diagnozy5:

  • Anty-HAV IgM (+) / Anty-HAV IgG (-): Ostre zakażenie HAV20
  • Anty-HAV IgM (+) / Anty-HAV IgG (+): Ostre zakażenie HAV, które wystąpiło w ciągu ostatnich sześciu miesięcy20
  • Anty-HAV IgM (-) / Anty-HAV IgG (+): Odporność na HAV w wyniku przebytego zakażenia lub szczepienia2017
  • Anty-HAV IgM (-) / Anty-HAV IgG (-): Brak odporności na HAV, podatność na zakażenie18

Wykrycie przeciwciał anty-HAV IgM przy braku objawów klinicznych może odzwierciedlać przedłużone utrzymywanie się IgM po przebytym zakażeniu, wynik fałszywie dodatni lub bezobjawowe zakażenie (częstsze u dzieci poniżej 6. roku życia)15.

Badania biochemiczne oceniające funkcję wątroby

Oprócz testów serologicznych, w diagnostyce WZW A pomocne są badania oceniające funkcję wątroby116:

  • Aminotransferazy: Aktywność aminotransferazy alaninowej (ALT) i asparaginianowej (AST) zwykle jest podwyższona, przy czym wartości ALT są wyższe niż AST. W ostrym WZW A poziomy enzymów wątrobowych mogą osiągać wartości rzędu 1000 j/l621. Wzrost aktywności tych enzymów pojawia się około 4 tygodnie po ekspozycji, na początku objawów klinicznych. Wartości wracają do normy w ciągu kilku tygodni, choć mogą pozostać podwyższone przez kilka miesięcy22.
  • Bilirubina: Poziom bilirubiny wzrasta wkrótce po wzroście aktywności aminotransferaz. Poziom może być bardzo wysoki i utrzymywać się przez kilka miesięcy23.
  • Fosfataza alkaliczna: Jej aktywność wzrasta wraz z aktywnością aminotransferaz23.
  • Albuminy: Mogą wystąpić umiarkowane spadki poziomu albumin w surowicy23.
  • Czas protrombinowy (PT): Zwykle pozostaje w normie i wymaga oznaczenia tylko w nietypowych przypadkach lub przy powikłaniach. Wydłużenie PT ponad pięciokrotnie jest oznaką ciężkiego zakażenia23.

Badania molekularne w diagnostyce WZW A

Metody molekularne, takie jak amplifikacja RNA wirusa HAV za pomocą reakcji RT-PCR (reverse transcription polymerase chain reaction), są obecnie najbardziej czułymi i szeroko stosowanymi metodami wykrywania RNA HAV24. Badania te mogą być przydatne w następujących sytuacjach:

  • Wykrywanie HAV w próbkach klinicznych (surowica, kał), środowiskowych lub żywnościowych2425
  • Badania epidemiologiczne, identyfikacja źródeł zakażenia i dynamiki ewolucji wirusa24
  • Wykrywanie HAV RNA we wczesnej fazie zakażenia, przed pojawieniem się przeciwciał anty-HAV IgM20

RNA wirusa HAV jest obecne we krwi i kale wkrótce po zakażeniu (gdy pacjent jest jeszcze bezobjawowy) i utrzymuje się do 1-2 tygodni po wystąpieniu objawów20.

Metody molekularne są bardziej czułe niż testy immunologiczne wykrywające antygeny wirusa24. Jednak w rutynowej diagnostyce klinicznej rzadko są potrzebne do postawienia diagnozy ostrego zakażenia HAV52.

Badania obrazowe i biopsja wątroby

Badania obrazowe zwykle nie są wskazane w diagnostyce WZW A17. Mogą być jednak przydatne w niektórych sytuacjach klinicznych:

  • Ultrasonografia wątroby może być wykonana w celu wykluczenia innych rozpoznań, takich jak niedrożność dróg żółciowych1526.
  • Cholangiografia zwykle nie jest wskazana w WZW A15.

Biopsja wątroby odgrywa minimalną rolę w diagnostyce ostrego zakażenia HAV527. Może być stosowana w przypadkach, gdy rozpoznanie jest niejasne lub gdy podejrzewa się nawrót choroby27.

W badaniu histopatologicznym widoczne jest nasilone zapalenie okołowrotne we wczesnej fazie choroby, co jest zgodne z obrazem wirusowego zapalenia wątroby17.

Postępowanie diagnostyczne w przypadku podejrzenia WZW A

Podejrzenie WZW A powinno być wysunięte u pacjentów z nagłym wystąpieniem objawów prodromalnych (nudności, brak apetytu, gorączka, złe samopoczucie lub ból brzucha) i żółtaczką lub podwyższonym poziomem aminotransferaz w surowicy, szczególnie w przypadku znanych czynników ryzyka transmisji wirusa HAV10.

Zalecane postępowanie diagnostyczne obejmuje61:

  1. Zebranie wywiadu medycznego, w tym informacji o potencjalnych czynnikach ryzyka lub narażeniu na HAV28
  2. Badanie fizykalne, ze szczególnym uwzględnieniem oceny wątroby i objawów żółtaczki29
  3. Badania laboratoryjne pierwszego rzutu6:
    • Aminotransferazy w surowicy (ALT, AST)
    • Bilirubina w surowicy
    • Azot mocznikowy (BUN)
    • Kreatynina w surowicy
    • Czas protrombinowy (PT)
    • Przeciwciała anty-HAV IgM
  4. Badania do rozważenia6:
    • Przeciwciała anty-HAV IgG
    • Wykrywanie RNA wirusa HAV

Różnicowanie z innymi chorobami wątroby

WZW A należy różnicować z innymi chorobami, które powodują gorączkę, nudności, wymioty, żółtaczkę, powiększenie wątroby, żółte zabarwienie twardówki, podwyższone wartości ALT, AST i dodatni wynik PCR, takimi jak30:

  • Inne wirusowe zapalenia wątroby (WZW B, WZW C, WZW E)
  • Alkoholowe zapalenie wątroby
  • Autoimmunologiczne zapalenie wątroby

W różnicowaniu tych stanów kluczowe znaczenie mają badania serologiczne30. Dla każdego typu wirusa zapalenia wątroby charakterystyczne są specyficzne przeciwciała30.

Zgłaszanie przypadków WZW A

Przypadki WZW A podlegają obowiązkowemu zgłoszeniu do lokalnych lub państwowych służb zdrowia publicznego, zgodnie z przepisami krajowymi1416. Szybkie zgłaszanie przypadków jest istotne dla zapobiegania dalszej transmisji wirusa i prowadzenia dochodzenia epidemiologicznego5.

Pozytywne wyniki testów anty-HAV IgM muszą być pilnie zgłaszane odpowiednim służbom zdrowia publicznego w celu przeprowadzenia dochodzeń epidemiologicznych dotyczących możliwej transmisji ogniskowej31.

Szybkie testy diagnostyczne w WZW A

Obecnie dostępne są szybkie testy immunochromatograficzne (ICA, rapid tests) do wykrywania przeciwciał przeciwko HAV11. Testy te mogą być skutecznym narzędziem w diagnostyce klinicznej i badaniach epidemiologicznych ognisk zakażeń ze względu na ich prostotę, szybkość i swoistość11.

Trwają również prace nad opracowaniem czułych i ekonomicznych metod wykrywania wirusów zapalenia wątroby, w tym szybkich kolorometrycznych testów, które mogłyby być stosowane w miejscu opieki nad pacjentem, oraz testów umożliwiających jednoczesne wykrywanie wielu patogenów32.

Diagnostyka różnicowa wirusowego zapalenia wątroby typu A

W diagnostyce różnicowej WZW A należy uwzględnić inne przyczyny ostrego zapalenia wątroby3334. Podstawowe badania diagnostyczne w tym kierunku obejmują3534:

  • Panel ostrego wirusowego zapalenia wątroby, który wykrywa markery trzech najczęstszych typów wirusowego zapalenia wątroby w Stanach Zjednoczonych: WZW A, B i C35.
  • Badania immunologiczne w kierunku autoimmunologicznego zapalenia wątroby, w tym oznaczanie immunoglobuliny G (IgG) w surowicy i charakterystycznych autoprzeciwciał36.
  • Dodatkowe badania związane z nieinfekacyjnymi przyczynami zapalenia wątroby37.

W diagnozie różnicowej pomocne mogą być również badania obrazowe, takie jak ultrasonografia, tomografia komputerowa (CT), rezonans magnetyczny (MRI) lub zdjęcia rentgenowskie, a także biopsja wątroby37.

Marker serologiczny Czas pojawienia się Czas utrzymywania się Interpretacja wyniku dodatniego
Anty-HAV IgM 5-10 dni przed objawami (15-45 dni po ekspozycji) 3-6 miesięcy (do 12 miesięcy) Ostre lub niedawne zakażenie HAV
Anty-HAV IgG Wkrótce po IgM Latami, często przez całe życie Przebyte zakażenie HAV lub szczepienie
Całkowite anty-HAV Aktualne/przebyte zakażenie HAV lub szczepienie
HAV RNA Wkrótce po zakażeniu (faza bezobjawowa) Do 1-2 tygodni po wystąpieniu objawów Wczesna faza ostrego zakażenia HAV

Podsumowanie diagnostyki WZW A

Diagnostyka wirusowego zapalenia wątroby typu A opiera się przede wszystkim na badaniach serologicznych wykrywających specyficzne przeciwciała przeciwko wirusowi HAV2. Złotym standardem w rozpoznawaniu ostrego zakażenia HAV jest wykrycie przeciwciał anty-HAV klasy IgM w surowicy pacjenta27.

Badania biochemiczne oceniające funkcję wątroby, szczególnie oznaczanie aktywności aminotransferaz, stanowią cenne uzupełnienie diagnostyki serologicznej11. Metody molekularne, takie jak RT-PCR, mogą być przydatne w określonych sytuacjach klinicznych i badaniach epidemiologicznych24.

Prawidłowa interpretacja wyników badań diagnostycznych, w połączeniu z oceną obrazu klinicznego i wywiadu epidemiologicznego, pozwala na postawienie właściwego rozpoznania i wdrożenie odpowiedniego postępowania, które ma na celu zarówno leczenie pacjenta, jak i zapobieganie dalszej transmisji wirusa HAV18.

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 10.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Clinical Overview of Hepatitis A | Hepatitis A | CDC
    https://www.cdc.gov/hepatitis-a/hcp/clinical-overview/index.html
    You will not be able to differentiate hepatitis A virus from other types of viral hepatitis using clinical or epidemiological features alone. Clinicians should conduct test(s) to make an accurate diagnosis. […] The following are laboratory markers that, if present, indicate an acute HAV infection: Immunoglobulin M antibodies to HAV (IgM anti-HAV) in serum, or HAV RNA in serum or stool. […] Serologic tests for IgG anti-HAV and total anti-HAV (IgM and IgG anti-HAV combined) are not helpful in diagnosing acute illness. You should only test patients for IgM anti-HAV if they are symptomatic, and you suspect HAV infection. Alanine aminotransferase (ALT) and total bilirubin tests can aid in diagnosis.
  • #2 Hepatitis A | AAFP
    https://www.aafp.org/pubs/afp/issues/2021/1000/p368.html
    Hepatitis A is a common viral infection worldwide that is transmitted via the fecal-oral route. […] Diagnosis of acute infection requires the use of serologic testing for immunoglobulin M antihepatitis A antibodies. […] The diagnosis of hepatitis A cannot be made solely on clinical grounds. […] Similarly, although epidemiologic factors may suggest hepatitis A, serologic testing is required to confirm the diagnosis. […] Immunoglobulin M (IgM) antihepatitis A antibodies generally become detectable five to 10 days before the onset of symptoms, peak within one month of illness, and can persist for more than six months. […] Testing is recommended only for symptomatic patients with suspected hepatitis A. […] Total antihepatitis A contains measurements of both IgM and IgG, and it can be used to identify unimmunized patients who are immune because of previous hepatitis A. […] Molecular virology methods may be useful in the investigation of common-source outbreaks of hepatitis A but are not necessary for routine clinical diagnosis.
  • #3 Clinical Screening and Diagnosis for Hepatitis A | Hepatitis A | CDC
    https://www.cdc.gov/hepatitis-a/hcp/diagnosis-testing/index.html
    The results of a blood tests will determine if a person is infected with the hepatitis A virus (HAV). […] Diagnosis and prompt administration of postexposure prophylaxis (PEP) to potentially exposed contacts can interrupt transmission. […] A blood test can confirm a suspected case of hepatitis A. The types of diagnostic tests used to confirm an HAV infection include serologic testing and, occasionally, PCR-based tests. […] You will not be able to differentiate hepatitis A virus from other types of viral hepatitis using clinical or epidemiological features alone. Clinicians should conduct test(s) to make an accurate diagnosis. […] The following are laboratory markers that, if present, indicate an acute HAV infection: Immunoglobulin M antibodies to HAV (IgM anti-HAV) in serum, or HAV RNA is serum or stool.
  • #4 Diagnosis of Hepatitis A Virus Infection: a Molecular Approach
    https://pmc.ncbi.nlm.nih.gov/articles/PMC1360271/
    Current serologic tests provide the foundation for diagnosis of hepatitis A and hepatitis A virus (HAV) infection. […] These new diagnostic methods have provided tools for the rapid detection of food-borne HAV transmission and identification of the potential source of the food contamination. […] Diagnostically, IgM anti-HAV has been used as the primary marker of acute infection; it is comprised mainly of antibodies against capsid proteins. […] The presence of total anti-HAV and the absence of IgM anti-HAV can be used to differentiate between past and current infections. […] The commercially available diagnostic assays are configured in such a manner that although IgM antibodies may be present for long periods of time, the lower concentrations found 4 to 6 months after the onset of infection do not produce a positive test result.
  • #5 Hepatitis A Workup: Approach Considerations, Complete Blood Count and Coagulation Study, Liver Function Tests
    https://emedicine.medscape.com/article/177484-workup
    Nucleic acid testing (NAT) is the gold standard for the diagnosis of viremic stages of hepatitis infection. […] One of the most common reasons for the misdiagnosis of hepatitis A infection is misinterpretation of the serology tests. […] Liver biopsy has a minimal role in the diagnosis acute of HAV infection. […] Molecular diagnostic techniques performed on blood and feces for HAV RNA are purely research tools at present. […] After establishing a diagnosis of hepatitis A virus (HAV) infection, tracing contacts and notifying local public health authorities are important steps for preventing further cases. […] The diagnosis of acute HAV infection is based on serologic testing for immunoglobulin M (IgM) antibody to HAV. […] This test is sensitive and specific, and the results remain positive for 3-6 months after the primary infection and for as long as 12 months in 25% of patients.
  • #6 Hepatitis A – Symptoms, diagnosis and treatment | BMJ Best Practice US
    https://bestpractice.bmj.com/topics/en-us/126?locale=th&
    Hepatitis A is one of the most frequently reported infectious diseases in the US. […] Immunoglobulin M anti-hepatitis A virus serology is the test of choice for diagnosis. […] Common exam findings are hepatomegaly and clinical jaundice with marked elevation of serum aminotransferases (usually 1000 units/L). […] Key diagnostic factors include fever, malaise, nausea and vomiting, jaundice, hepatomegaly, right upper quadrant pain, and clay-colored stools. […] 1st tests to order include serum aminotransferases, serum bilirubin, BUN, serum creatinine, prothrombin time, and IgM anti-hepatitis A virus (HAV). […] Tests to consider include IgG anti-hepatitis A virus (HAV) and hepatitis A virus RNA detection.
  • #7 Hepatitis A (Hep A): Symptoms, Causes, Diagnosis, and Treatment
    https://www.webmd.com/hepatitis/digestive-diseases-hepatitis-a
    Your doctor will first ask about your symptoms and check for high levels of liver enzymes in your blood. Then, you’ll have blood taken for testing to look for hepatitis antigens and antibodies. […] Antigens are substances in the hepatitis virus. Antibodies are substances your immune system makes to fight off the virus. There are two types: […] IgM (immunoglobulin M) antibodies. Your body makes these when you’re first exposed to hepatitis A. They stay in your blood for about 3-6 months. […] IgG (immunoglobulin G) antibodies. These show up after the virus has been in your body for a while. You may have them all your life. They protect you against hepatitis A. If you test positive for them but not for IgM antibodies, it means you had a hepatitis A infection in the past or had vaccinations to protect against it.
  • #8 Hepatitis A Testing – Testing.com
    https://www.testing.com/tests/hepatitis-a-test/
    Hepatitis A testing detects evidence of a current or past hepatitis A infection. […] Testing is performed on a sample of a patient’s blood. Hepatitis A testing may be used to diagnose hepatitis A and assess whether a person has immunity to this disease. […] The purpose of hepatitis A testing is to determine if a person has been infected by the hepatitis A virus (HAV). […] A doctor may order hepatitis A testing for several purposes: Diagnose current infection: Doctors use hepatitis tests to diagnose the cause of hepatitis in patients with signs and symptoms of this disease. […] Hepatitis A testing looks for two types of antibodies. […] Although testing the blood for HAV antibodies is the gold standard for identifying a hepatitis A infection, other tests may be ordered that instead look for the genetic material of the hepatitis A virus.
  • #9 Hepatitis A | Johns Hopkins ABX Guide
    https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540260/all/Hepatitis_A
    Hepatitis A virus (HAV) is a picornavirus, a non-enveloped single-stranded RNA virus. […] A highly contagious virus acquired by fecal-oral route either by person-person contact, sexual contact, or ingestion of contaminated food/water. […] In developed countries with universal HAV immunization, international travel to endemic regions is now the most significant risk factor. […] The incubation period is typically 15-50d, average of 28d. […] Symptoms: illness with usually an abrupt onset of acute hepatitis: dark urine, jaundice, fever, malaise, nausea, vomiting, abdominal pain, arthralgia, acholic stools. […] Ddx: clinical symptoms of HAV nonspecific, cannot distinguish from other common causes of hepatitis (HBV, HCV, EBV, enteroviruses, HME/HGA, leptospirosis, etc). […] Dx: Serology: HAV IgM antibody diagnostic, may be positive 5-10d prior to the onset of sx.
  • #10 Hepatitis A virus infection in adults: Epidemiology, clinical manifestations, and diagnosis – UpToDate
    https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis
    Hepatitis A virus infection in adults: Epidemiology, clinical manifestations, and diagnosis […] The epidemiology, clinical manifestations, diagnosis, and treatment of HAV infection in adults are reviewed here. […] The diagnosis of acute HAV infection should be suspected in patients with abrupt onset of prodromal symptoms (nausea, anorexia, fever, malaise, or abdominal pain) and jaundice or elevated serum aminotransferase levels, particularly in the setting of known risk factors for hepatitis A transmission (table 1). […] The diagnosis is established by detection of serum IgM anti-HAV antibodies. Serum IgM antibodies are detectable at the time of symptom onset, peak during the acute or early convalescent phase of the disease, and remain detectable for approximately three to six months (figure 2).
  • #11 Laboratory Diagnosis of Hepatitis A – Page 4
    https://www.medscape.com/viewarticle/765040_4
    The specificity of detection of IgM anti-HAV antibodies for the diagnosis of hepatitis A is approximately 99-100% sensitivity, with a positive predictive value of 88%. […] A multicenter evaluation of commercial enzyme immunoassays for the detection of IgM and total antibodies against HAV confirmed the good performance of assays, with 99.85 and 99.47% overall agreement in detecting total antibodies and IgM, respectively. […] Until now, only one immunochromatographic assay (ICA; rapid test) has been available to detect HAV antibodies. […] The ICA for the detection of anti-HAV IgM will be a very effective rapid assay when applied to clinical diagnosis and the epidemiological investigation of outbreaks owing to its simplicity, rapidity and specificity. […] The HAV viral antigen can be detected in feces, serum, saliva, cell culture and environmental samples, usually by means of immunoassays or molecular tests.
  • #11 Laboratory Diagnosis of Hepatitis A – Page 4
    https://www.medscape.com/viewarticle/765040_4
    Biochemical tests of liver function can be used as auxiliary diagnosis for viral hepatitis, and include measurement of serum total bilirubin, alkaline phosphatase, ALT and aspartate aminotransferase (AST), but only ALT is a specific test for hepatitis. […] Clinical and biochemical testing does not allow the differentiation of hepatitis A from other forms of acute hepatitis, so serological tests are needed to identify the etiologic agent. […] The laboratory diagnosis of hepatitis A can be made by specific serological tests for detection of anti-HAV IgM. […] The specific serodiagnosis is accomplished by examining anti-HAV antibodies of the IgM class, which are the main markers of acute infection with HAV. […] Generally, the detection of these antibodies is performed by enzyme immunoassay (sandwich assay), with several commercially available diagnostic kits.
  • #12 Hepatitis A | Johns Hopkins ABX Guide
    https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540260/all/Hepatitis_A
    IgM anti-HAV remains elevated for up to 12 months after the resolution of infection. […] The total anti-HAV test detects both IgM and IgG, so if positive, may reflect prior exposure. […] Molecular: Detection of viral RNA by PCR in blood or stool specimens possible, but uncommonly needed to make a diagnosis of acute HAV infection. […] If fulminant hepatitis develops due to HAV, mortality is up to 80%. […] Most symptoms resolve within 8 weeks, although 10-15% have problems for up to 6 months. […] Chronic HAV does not exist. […] The report builds on earlier case descriptions of likely false positive HAV IgM tests.
  • #13 Hepatitis A | Cleveland Clinic
    https://my.clevelandclinic.org/departments/digestive/medical-professionals/hepatology/hepatitis-a
    Detecting IgM anti-HAV in the serum of a patient with the clinical and biochemical features of acute hepatitis usually confirms the diagnosis of acute hepatitis A. […] HAV antigen can be detected in the stool or body fluids, but there is no commercially available assay. Detecting viral RNA is highly specific but expensive and is rarely used to confirm the diagnosis. […] Testing for anti-HAV IgG is not helpful in the diagnosis but is a means of assessing immunity to hepatitis A. When detected in the serum, this IgG remains positive for years.
  • #14 Clinical Screening and Diagnosis for Hepatitis A | Hepatitis A | CDC
    https://www.cdc.gov/hepatitis-a/hcp/diagnosis-testing/index.html
    Serologic tests for IgG anti-HAV and total anti-HAV (IgM and IgG anti-HAV combined) are not helpful in diagnosing acute illness. You should only test patients for IgM anti-HAV if they are symptomatic, and you suspect HAV infection. Alanine aminotransferase (ALT) and total bilirubin tests can aid in diagnosis. […] Clinicians should assess a patient’s history (including potential risk behaviors or exposures for HAV infection), physical exam, and test results in determining whether hepatitis A is the appropriate clinical diagnosis for a patient. […] Clinicians and health care providers should report cases of hepatitis A to health departments as specified by state, territorial, and local regulations.
  • #15 Hepatitis A virus infection in adults: Epidemiology, clinical manifestations, and diagnosis – UpToDate
    https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis
    Detection of serum IgM antibodies in the absence of clinical symptoms may reflect prior HAV infection with prolonged persistence of IgM, a false-positive result, or asymptomatic infection (which is more common in children <6 years of age than in older children or adults). [...] Serum IgG antibodies appear early in the convalescent phase of the disease, remain detectable for decades, and are associated with lifelong protective immunity (figure 2). [...] Detection of anti-HAV IgG in the absence of anti-HAV IgM reflects past infection or vaccination rather than acute infection. [...] Imaging studies are generally not indicated for diagnosis of HAV infection. Ultrasonography may sometimes be appropriate to rule out alternative diagnoses (such as biliary obstruction); cholangiography or liver biopsy are usually not indicated.
  • #16 Hepatitis A – Hepatic and Biliary Disorders – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/hepatic-and-biliary-disorders/hepatitis/hepatitis-a
    Hepatitis A is caused by an enterically transmitted RNA virus that, in older children and adults, causes typical symptoms of viral hepatitis, including anorexia, malaise, and jaundice. […] Diagnosis is by antibody testing. […] If the IgM anti-HAV test is positive, acute hepatitis A is diagnosed. […] A positive IgG anti-HAV test suggests prior HAV infection or acquired immunity. […] There is no further testing for hepatitis A. […] IgM antibody is a marker of acute infection, whereas IgG anti-HAV indicates only previous exposure to HAV and immunity to recurrent infection. […] No treatments attenuate acute viral hepatitis, including hepatitis A. […] Hepatitis A should be reported to the local or state health department. […] Routine vaccination beginning at age 1 is recommended for all. […] Vaccinate people at risk (eg, travelers to endemic areas, laboratory workers), and provide postexposure prophylaxis in those who are not previously vaccinated.
  • #17 Hepatitis A Workup: Approach Considerations, Complete Blood Count and Coagulation Study, Liver Function Tests
    https://emedicine.medscape.com/article/177484-workup
    The presence of anti-HAV IgG in the absence of IgM indicates past infection or vaccination rather than acute infection. […] Imaging studies are usually not indicated in HAV infection. […] Histopathology reveals pronounced portal inflammation early in the illness, which is consistent with viral hepatitis.
  • #18 Hepatitis A Virus Total Antibodies, Serum – Mayo Clinic Laboratories | Pediatric Catalog
    https://pediatric.testcatalog.org/show/HAVTA
    This assay detects the presence of hepatitis A virus (HAV)-specific total antibodies (both anti-HAV IgG and anti-HAV IgM combined). A positive result indicates that the patient had hepatitis A either recently or in the past or immunity to hepatitis A from vaccination. A reactive (positive) result by the Elecsys Anti-HAV II assay does not differentiate between acute or past HAV infection or immunity from vaccination, and it does not necessarily rule out other hepatitis infections. […] If clinically indicated, specific testing for anti-HAV IgM is necessary to confirm the presence of acute or recent hepatitis A. A positive result for anti-HAV total with a negative anti-HAV IgM result indicates immunity to hepatitis A from either past HAV infection or vaccination against HAV. […] A negative result indicates the absence of recent or past hepatitis A or a lack of immunity to HAV infection. A non-reactive (negative) test result does not exclude the possibility of early acute infection with HAV. […] For diagnostic purposes, the results should always be assessed in conjunction with the patient’s medical history, clinical examination, and other findings. […] Regardless of exposure history, testing for anti-HAV total antibodies alone is insufficient to confirm a diagnosis of acute hepatitis A.
  • #19 Hepatitis A, AB total reactive: What does it mean?
    https://www.medicalnewstoday.com/articles/hepatitis-a-ab-total-reactive
    The hepatitis A virus (HAV) antibody (AB) total test identifies both types of antibodies that the body produces in response to HAV infection. A reactive result means the test has detected HAV antibodies. […] A total reactive result means the HAV antibody test result is positive. This means the test has detected HAV antibodies in the blood. A reactive or positive test result means a person has had one of the following: a current HAV infection, a previous HAV infection, an HAV vaccination that is effective. […] If a hepatitis A antibody test is reactive or positive, it means people have developed HAV antibodies in response to a HAV infection or vaccination. […] A hepatitis A (HAV) antibody (AB) total reactive result means that people have tested positive for both antibodies, which indicates a current or previous HAV infection or effective HAV vaccination.
  • #20 Diagnosis of Hepatitis A Infection | Marler Clark
    https://marlerclark.com/foodborne-illnesses/hepatitis-a/hepatitis-diagnosis
    Hepatitis A infection is typically diagnosed through blood tests. […] Therefore, neither the individual nor the healthcare provider can tell by symptoms or signs if a given individual is suffering from hepatitis A unless laboratory tests are performed. […] Fortunately, blood tests are widely available to accurately diagnose hepatitis A, including tests for antibodies, or the affected persons immune response to hepatitis A proteins. This immune response is conclusively demonstrated by the presence of Immunoglobulin M (IgM) antibodies, indicating acute disease, and immunoglobulin G (IgG), indicating a past infection or vaccination. […] For a positive hepatitis A diagnosis, HAV RNA is present in blood and feces soon after infection (while an individual is asymptomatic), until 1 to 2 weeks after the onset of symptoms. […] IgM positive / IgG negative: This result indicates acute hepatitis A. […] IgM positive / IgG positive: This result indicates that acute hepatitis A occurred within the last six months. […] IgM negative / IgG positive: Persons with this result are immune to hepatitis A.
  • #21 Hepatitis A Causes, Symptoms, Diagnosis and Treatment – Cura4U
    https://cura4u.com/conditions/hepatitis-a
    With the onset of symptoms, roughly four weeks after exposure, liver enzymes such as Alanine aminotransferase (ALT) rise more than aspartate aminotransferase (AST). Levels normally return to normal within a few weeks, although they can stay high for months. Alkaline phosphatase (ALP) levels also rise in conjunction with ALT and AST.
  • #22 Hepatitis A | Doctor
    https://patient.info/doctor/hepatitis-a-pro
    Diagnosing hepatitis A (investigations) […] Specific antibody tests […] IgM antibody to HAV is positive with onset of symptoms (usually about 3-4 weeks after exposure but up to six weeks). The test is sensitive and specific. It remains positive for between 3-6 months (up to 12 months). It remains positive in relapsing hepatitis. […] […] IgG antibody to HAV appears soon after IgM and persists for many years. In the absence of IgM it indicates past infection or vaccination rather than acute infection. IgG remains detectable for life. […] Liver enzymes […] Alanine aminotransferase (ALT) rises more than aspartate aminotransferase (AST) again with onset of symptoms, about four weeks after exposure. Levels usually return to reference ranges over several weeks but can remain elevated for months.
  • #23 Hepatitis A | Doctor
    https://patient.info/doctor/hepatitis-a-pro
    Alkaline phosphatase rises with ALT and AST. […] Other test results […] Bilirubin rises soon after rises in ALT and AST levels. Levels may be very high and remain elevated for several months. Older patients have higher bilirubin levels. […] Modest falls in serum albumin level may occur. […] Prothrombin time (PT) usually remains normal and estimation is necessary only in unusual cases or with complications. PT prolongation by more than five times is a sign of severe infection. […] Indices of low-grade haemolysis may be detected. […] Mild lymphocytosis is common. […] Pure red cell aplasia and pancytopenia may very rarely occur. […] Imaging Ultrasound may, rarely, be needed to exclude other diseases.
  • #24 Diagnosis of Hepatitis A Virus Infection: a Molecular Approach
    https://pmc.ncbi.nlm.nih.gov/articles/PMC1360271/
    Nucleic acid detection techniques are more sensitive than immunoassays for viral antigen to detect HAV in samples of different origins (e.g., clinical specimens, environmental samples, or food). […] Amplification of viral RNA by RT-PCR is currently the most sensitive and widely used method for detection of HAV RNA. […] Molecular epidemiology has played an important role in improving the understanding of HAV infection by identifying sources of infection and the dynamics of virus evolution. […] Molecular epidemiologic investigations have to be planned and conducted with equal attention being paid to the methodological requirements of both disciplines: epidemiology and molecular biology.
  • #25 Tests and diagnosis for hepatitis A – British Liver Trust
    https://britishlivertrust.org.uk/information-and-support/liver-conditions/hepatitis-a/diagnosis/
    Hepatitis A can be diagnosed using blood tests. […] You might have blood tests to check for viral hepatitis if your doctor thinks you have a liver problem but doesnt know what is causing it yet. This is a routine test to check for all possible causes. […] Blood tests for hepatitis A look for antibodies against the virus (antibody test). And for small amounts of the genetic instructions from the virus (PCR test). […] This test will look for antibodies against hepatitis A in your blood. […] A PCR test can look for tiny amounts of the viruss RNA. This is the genetic instructions that the virus uses to make copies of itself.
  • #26 Hepatitis A Virus: Spread, Factors and Diagnosis | Ganesh Diagnostic
    https://www.ganeshdiagnostic.com/blog/hepatitis-a-virus-spread-factors-and-diagnosis
    Diagnosing acute Hepatitis A typically involves blood tests to detect specific antibodies produced by the body in response to the virus. The key diagnostic marker for acute infection is the presence of IgM (immunoglobulin M) antibodies against HAV. These antibodies appear early in the infection. […] IgG (immunoglobulin G) antibodies against HAV develop shortly after the IgM antibodies and persist for life, indicating past infection and immunity. […] A serological test that detects these HAV-specific IgM antibodies in the blood is the standard diagnostic procedure for acute Hepatitis. […] Routine blood tests may also reveal mild lymphocytosis (an increase in white blood cells called lymphocytes) and a normal prothrombin time (a measure of blood clotting ability). An increased prothrombin time should raise suspicion for more severe liver damage and the potential risk of encephalopathy (brain dysfunction due to liver failure). Hepatitis A is associated with elevated levels of the liver enzyme aspartate aminotransferase (AST), which usually returns to normal within 4 to 6 months. Bilirubin levels, a marker of jaundice, are also typically elevated and, if they remain high, may suggest cholestatic liver disease. […] Ultrasonography (imaging of the liver using sound waves) is generally not required for diagnosing typical cases of HAV.
  • #27 Hepatitis A laboratory findings – wikidoc
    https://www.wikidoc.org/index.php/Hepatitis_A_laboratory_findings
    Hepatitis A cannot be differentiated from other types of viral hepatitis on the basis of clinical or epidemiologic features alone. Laboratory tests are required for its diagnosis. Serologic tests in hepatitis A virus (HAV) infection reveal elevated IgM anti-HAV in the acute phase (gold standard) in addition to an elevated IgG anti-HAV that remains elevated for the person’s lifetime. Additional laboratory findings include the detection and sequencing of HAV RNA, an elevated direct bilirubin, and elevated liver enzymes. Liver biopsy has a minimal role in the diagnosis of HAV infection and it is only used when the diagnosis is unclear or when relapse is suspected. […] Serologic testing to detect immunoglobulin M (IgM) antibody to the capsid proteins of HAV (IgM anti-HAV) is required to confirm the diagnosis of acute HAV infection. […] Immunoglobulin M (IgM) anti-HAV is the gold standard for the detection of acute illness. […] The role of a liver biopsy is minimal in the diagnosis of hepatitis A. It may be used in cases involving chronic relapsing hepatitis A or when the diagnosis is unclear.
  • #28 Hepatitis A – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/hepatitis-a/diagnosis-treatment/drc-20367055
    Blood tests are used to look for signs of the hepatitis A virus in your body. A sample of blood is taken, usually from a vein in your arm. It’s sent to a laboratory for testing. […] If you have symptoms of hepatitis A, make an appointment with your health care provider. […] Your health care provider is likely to ask you a number of questions, including: Have you recently traveled or been exposed to someone with hepatitis A?
  • #29 Hepatitis A: Symptoms, What It Is, Transmission & Treatment
    https://my.clevelandclinic.org/health/diseases/21198-hepatitis-a
    Hepatitis A is a liver disease caused by the hepatitis A virus (HAV). Its a very contagious disease. It spreads through close person-to-person contact. […] A healthcare provider will do a physical examination. Theyll look for signs like an enlarged liver, an enlarged spleen or symptoms of jaundice. They may order liver function tests. These tests check your blood for specific antibodies. […] Theres no specific treatment for hepatitis A infection. Your healthcare provider may recommend that you: Stay home: You should stay home from school or work until your fever goes away and you dont have jaundice symptoms. […] Yes, it can. Getting vaccinated against hepatitis A is the easiest way to prevent it. Healthcare providers recommend hepatitis A vaccinations for people over 12 months of age who: Are exposed to the virus at their jobs. […] Hepatitis A doesnt require treatment to cure it. It goes away on its own. But it may be weeks or a few months before you feel better.
  • #30 Hepatitis A differential diagnosis – wikidoc
    https://www.wikidoc.org/index.php/Hepatitis_A_differential_diagnosis
    Hepatitis A must be differentiated from other diseases that cause fever, nausea, vomiting, jaundice, hepatomegaly, icteric sclera, elevated ALT, AST, and PCR such as other viral hepatitis, alcoholic hepatitis, and autoimmune hepatitis. […] Serologic testing will help differentiate these two conditions. […] Serologic testing will help differentiate these two conditions. […] Serologic testing will help differentiate these two conditions. […] Serologic testing will help differentiate these two conditions. […] Serologic testing will help differentiate these two conditions. […] Specific viral antibody for each type. […] Serologic testing will help differentiate these two conditions.
  • #31 Hepatitis A Virus IgM Antibody, Serum – Mayo Clinic Laboratories | Microbiology and Infectious Disease Catalog
    https://microbiology.testcatalog.org/show/HAIGM
    This assay detects the presence of hepatitis A virus (HAV)-specific IgM antibody in serum. Negative results indicate either inadequate or delayed anti-HAV IgM response after known exposure to HAV or absence of acute or recent hepatitis A. Equivocal results may be seen in early acute hepatitis A associated with rising anti-HAV IgM levels or recent hepatitis A infection associated with declining anti-HAV IgM levels. Retesting for both anti-HAV IgM (HAIGM / Hepatitis A Virus IgM Antibody, Serum) and anti-HAV Total (HAVTA / Hepatitis A Virus Total Antibodies, Serum) in 2 to 4 weeks is recommended to determine the definitive HAV infection status. […] Positive results indicate acute or recent (<6 months) hepatitis A infection. As required by laws in almost all states, positive anti-HAV IgM test results must be urgently reported to state health departments for epidemiologic investigations of possible outbreak transmission.
  • #32 Pathogenesis and Diagnosis of Hepatitis A Virus and Other Biodefense Agents | FDA
    https://www.fda.gov/vaccines-blood-biologics/science-research-biologics/pathogenesis-and-diagnosis-hepatitis-virus-and-other-biodefense-agents
    Hepatitis A virus (HAV) causes acute hepatitis in humans, and as a potential agent of bioterrorism (BT) it poses a threat to the safety of the blood supply. […] Tests to screen blood donations and diagnose viral infection for hepatitis viruses are widely used. […] The major obstacle to the development and preclinical assessment of reagents and tests to diagnose hepatitis virus infections is the inability of most hepatitis viruses to grow in cell cultures. […] We are also developing sensitive and cost-effective methods to detect hepatitis viruses and bioterrorism agents such as Ebola Virus and Marburg Virus in blood. […] We are currently developing rapid colorimetric tests that could be used at point-of-care and tests that will simultaneously detect multiple pathogens. […] HAVCR1 (CD365) and its mouse ortholog are functional hepatitis A virus (HAV) cellular receptors that mediate HAV infection.
  • #33 Hepatitis Testing – Testing.com
    https://www.testing.com/hepatitis-testing/
    The purpose of hepatitis tests is to screen for and diagnose hepatitis, evaluate the liver, and to determine the underlying cause of hepatitis: […] Hepatitis testing is typically ordered by a doctor in order to screen patients for hepatitis, to evaluate liver damage, or when there are signs or symptoms consistent with hepatitis. […] Hepatitis testing often begins with preliminary tests to evaluate the liver and detect evidence of hepatitis. Depending on the patient’s symptoms, medical history, and the results of a physical exam, a patient’s doctor may order individual tests or broad test panels such as a comprehensive metabolic panel and a liver panel. These tests may be used to evaluate the liver, detect evidence of hepatitis, and begin to narrow down the underlying cause of a patient’s condition.
  • #34 Viral Hepatitis Types, Causes, Symptoms, Diagnosis, Treatment
    https://www.medicinenet.com/viral_hepatitis/article.htm
    Hepatitis, or inflammation of the liver, most often is caused by hepatitis A, B, and C viruses. […] The most common hepatitis viruses are types A, B, and C. […] How is viral hepatitis diagnosed? […] Diagnosis of viral hepatitis is based on symptoms and physical findings as well as blood tests for liver enzymes, viral antibodies, and viral genetic materials. […] Diagnosis of acute viral hepatitis often is easy, but the diagnosis of chronic hepatitis can be difficult. […] There are three types of blood tests for evaluating patients with hepatitis: liver enzymes, antibodies to the hepatitis viruses, and viral proteins or genetic material (viral DNA or RNA). […] Among the most sensitive and widely used blood tests for evaluating patients with hepatitis are liver enzymes, called aminotransferases.
  • #35 Hepatitis Testing – Testing.com
    https://www.testing.com/hepatitis-testing/
    Tests used to diagnose, evaluate, and guide treatment for viral hepatitis may be performed individually when a person has a known or suspected exposure to a specific type of viral hepatitis. In patients without a known or expected exposure, tests may be performed together as part of an acute viral hepatitis panel. An acute viral hepatitis panel detects evidence of the three most common types of hepatitis in the United States: hepatitis A, B, and C. […] Hepatitis testing may also be recommended for patients who have symptoms of liver damage or abnormal liver function tests. Many patients experience few or no symptoms of acute hepatitis. When symptoms do occur, they may include: […] There are many tests used to screen for, diagnose, and evaluate hepatitis. Multiple tests are often necessary to understand a patient’s condition.
  • #36 Autoimmune Hepatitis: A Diagnostic and Therapeutic Overview
    https://www.mdpi.com/2075-4418/14/4/382
    Autoimmune hepatitis is an immune-mediated inflammatory condition of the liver of undetermined cause that affects both sexes, all ages, races, and ethnicities. The diagnosis is based on histological abnormalities (interface hepatitis), characteristic clinical and laboratory findings (increased aspartate aminotransferase, alanine aminotransferase, and serum IgG concentration), and the presence of one or more characteristic autoantibodies. […] An adequate and timely diagnosis allows an early start of immunosuppression, thus preventing the progression of liver injury. […] The diagnosis of AIH remains to this day a challenging task, considering the heterogenous clinical manifestation and broad age of presentation. […] The diagnosis of AIH can be established when characteristic histologic abnormalities (interface hepatitis), clinical and laboratory findings (elevated AST, ALT, and serum IgG) are present, along with one or more circulating antibodies.
  • #37 Hepatitis Testing – Testing.com
    https://www.testing.com/hepatitis-testing/
    If a non-infectious cause of hepatitis is suspected, a doctor may recommend other tests. Tests related to non-infectious hepatitis include: […] Additional tests involved in diagnosing hepatitis and evaluating liver damage include a liver biopsy and imaging tests. A liver biopsy involves using a needle to remove a small amount of liver tissue to examine under a microscope for evidence of liver damage or disease. Imaging tests that may be used include ultrasounds, CT scans, MRIs, or x-rays.